BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Biofuel
,
Fenofibrate
,
rs2230926
,
ZBTB7A
,
Angiogenesis
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rotigotine
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
The development of the rotigotine transdermal patch: a historical perspective.
Local effects of transdermal treatment with rotigotine].
Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in SD rats.
Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in Cynomolgus …
Rotigotine transdermal patch for the treatment of Parkinson's Disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Named Patient Program With Rotigotine Transdermal System
Switching From Oral Dopamine Agonists to Rotigotine
Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
MIRT and Rotigotine in the Early Stage of PD
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ